 |
 |

Esophageal Disease in Human Immunodeficiency Virus Infection
Loren Laine, MD;
Maurizio Bonacini, MD
Arch Intern Med. 1994;154(14):1577-1582.
Abstract
Up to 40% of patients with the acquired immunodeficiency syndrome may develop symptoms of esophageal disease. Candida esophagitis is responsible for the majority of the cases of esophageal disease; cytomegalovirus, herpes simplex, idiopathic esophageal ulcers, and Kaposi's sarcoma account for most of the remaining cases. Although endoscopy with esophageal biopsy and brushing is the gold standard for the diagnosis of esophageal disease in the acquired immunodeficiency syndrome, we generally recommend initial empiric therapy with an antifungal agent in patients with esophageal symptoms. Since effective treatment is available for most cases of esophageal disease in the acquired immunodeficiency syndrome, we recommend endoscopic evaluation in patients who do not respond to empiric therapy within 1 to 2 weeks. (Arch Intern Med. 1994;154:1577-1582)
Author Affiliations
From the Division of Gastrointestinal and Liver Diseases, Department of Medicine, University of Southern California School of Medicine, Los Angeles.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Haemin uptake and use as an iron source by Candida albicans: role of CaHMX1-encoded haem oxygenase
Santos et al.
Microbiology 2003;149:579-588.
ABSTRACT
| FULL TEXT
|